Author Archives: zymecom

← Older posts

Mogrify to host careers open day at Bio-Innovation Centre, Cambridge Science Park

Posted on by zymecom

The event will take place on Friday, 16th August 2019 from 4–6pm, at Mogrify offices, 25 Cambridge Science Park Opportunity to find out about careers in the biotech industry, tour the research laboratories and meet the founders and current employees … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Arcis Biotechnology and Mirnax Biosens sign exclusive license agreement for Arcis sample prep technology

Posted on by zymecom

Enables stabilisation of microRNA biomarkers for early disease diagnosis  Daresbury, UK, and Madrid, Spain, 16 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, and Mirnax Biosens (“Mirnax”), the developer of microRNA (miRNA) biomarkers for clinical diagnostics, … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

PhoreMost appoints Dr Lorenz Mayr as Non-Executive Director

Posted on by zymecom

Board appointment will help guide target identification and drug discovery Cambridge, UK, 15 July 2019: PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has appointed Dr Lorenz Mayr to its Board as Non-Executive … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

The Native Antigen Company Signs Distribution Agreement with BIOZOL and Shanghai Bioleaf

Posted on by zymecom

Sole distributor agreements covering Germany, Switzerland, Austria and China will improve access to high-quality viral and bacterial antigens, antibodies and immunoassay research reagents Oxford, UK, 11 July 2019: The Native Antigen Company, one of the world’s leading suppliers of reagents … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Start Codon strengthens senior team with key appointments

Posted on by zymecom

Daniel Rooke appointed Partner and Head of Operations Sakura Holloway appointed Partner and Head of Diligence  CAMBRIDGE, UK, 10th July, 2019 – Start Codon, a new model of life science and healthcare business accelerator, announced today two appointments to its … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Arcis Biotechnology and Opentrons sign distribution agreement

Posted on by zymecom

Providing researchers with an automated solution for two-step nucleic acid sample preparation  Daresbury, UK, 09 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

PhoreMost and inStem enter structural biology alliance

Posted on by zymecom

inStem’s Centre for Chemical Biology and Therapeutics to work with PhoreMost to progress selected targets Cambridge, UK, 08 July 2019: PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a structural biology … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

Horizon Discovery’s SMARTvector shRNA technology deployed in Celyad’s successful IND filing for next-generation CAR-T cell therapy, CYAD-02

Posted on by zymecom

Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology Horizon will receive a milestone payment for the successful IND filing of CYAD-02, autologous NKG2D-based CAR-T candidate Cambridge, UK, 8 July … Continue reading

Posted in News from Zyme and the companies we work with | Leave a comment

FUJIFILM Irvine Scientific Announces Construction of a New Cell Culture Media Manufacturing Site in Europe

Posted on by zymecom

New facility brings rapid, reliable delivery of cell culture media to European customers  SANTA ANA, California, 2 July, 2019: FUJIFILM Irvine Scientific, Inc., a global leader in the innovation, development, and manufacture of cell culture media, announced plans to open … Continue reading

Posted in News from Zyme and the companies we work with | Comments Off on FUJIFILM Irvine Scientific Announces Construction of a New Cell Culture Media Manufacturing Site in Europe

ERS Genomics provides comment on new patent interference with the Broad Institute relating to invention of the CRISPR/Cas9 system

Posted on by zymecom

DUBLIN, Ireland, 26 June 2019: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the U.S. Patent and Trademark Office (USPTO) declared a patent interference … Continue reading

Posted in News from Zyme and the companies we work with | Comments Off on ERS Genomics provides comment on new patent interference with the Broad Institute relating to invention of the CRISPR/Cas9 system ← Older posts
  • People

    An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.

  • Keep in touch

    +44(0) 1223 968 920

    info@zymecommunications.com


     

  • Upcoming Events

    Zyme Communications will be providing support for its clients attending the following events:

    71st AACC Annual Scientific Meeting & Clinical Lab Expo

    When: Sun August 4 09:00 - Thu August 8 18:00
    Where: California, USA

    Immuno-Oncology Summit

    When: Mon August 5 09:00 - Fri August 9 18:00
    Where: Boston, USA